Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
72.46
+0.95 (1.33%)
At close: May 8, 2025, 4:00 PM
61.00
-11.46 (-15.82%)
Pre-market: May 9, 2025, 6:04 AM EDT
Globus Medical Market Cap
Globus Medical has a market cap or net worth of $9.81 billion as of May 9, 2025. Its market cap has increased by 41.37% in one year.
Market Cap
9.81B
Enterprise Value
9.44B
1-Year Change
41.37%
Ranking
Category
Stock Price
$72.46
Market Cap Chart
Since August 3, 2012, Globus Medical's market cap has increased from $1.22B to $9.81B, an increase of 703.78%. That is a compound annual growth rate of 17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 9.84B | -12.67% |
| Dec 31, 2024 | 11.26B | 53.38% |
| Dec 29, 2023 | 7.34B | -0.98% |
| Dec 30, 2022 | 7.42B | 1.22% |
| Dec 31, 2021 | 7.33B | 13.84% |
| Dec 31, 2020 | 6.44B | 9.95% |
| Dec 31, 2019 | 5.85B | 37.32% |
| Dec 31, 2018 | 4.26B | 7.60% |
| Dec 29, 2017 | 3.96B | 66.61% |
| Dec 30, 2016 | 2.38B | -10.27% |
| Dec 31, 2015 | 2.65B | 17.98% |
| Dec 31, 2014 | 2.25B | 19.34% |
| Dec 31, 2013 | 1.88B | 96.83% |
| Dec 31, 2012 | 956.00M | -21.65% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 350.94B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |